FiveT Investment Management Ltd 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-24 12:27 pm Sale |
2023-02-22 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 223,500 4.780% |
-29,333 (-11.60%) |
Filing |
| 2023-01-31 11:59 am Unchanged |
2023-01-25 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 252,833 4.120% |
0 (Unchanged) |
Filing |
| 2022-01-11 12:04 pm Purchase |
2022-01-10 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 252,833 6.030% |
44,500 (+21.36%) |
Filing |
| 2021-12-15 12:52 pm Sale |
2021-12-14 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 208,333 4.970% |
-35,786 (-14.66%) |
Filing |
| 2021-06-21 12:01 pm Purchase |
2021-06-16 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 244,119 5.830% |
244,119 (New Position) |
Filing |